In human gliomas, some reports have documented that the increased expression of cytoplasmic Survivin, detected by immunohistochemistry (IHC), in gliomas was correlated with an ascending pathological grade of tumour (Sasaki et al, 2002; Jiao et al, 2004). This evidence concerns the gene BIRC5 and neoplasm.